​

Funding Round

Series B - AlgoTherapeutix

Series B - AlgoTherapeutix

Investment Firm

Overview

AlgoTherapeutix is the operator of a biotechnology company designed to develop topical treatments for complex pain.

Announced Date

Mar 14, 2023

Funding Type

Series B

Highlights

Location

Europe

Social

Investor Lead

Turenne Capital

Turenne Capital

Turenne Capital is a early_stage_venture and late_stage_venture and private_equity and seed and venture firm.

Participant Investors

4

Investor Name
Participant InvestorInnoBio Fund
Participant InvestorTurenne Capital
Participant InvestorBpifrance
Participant InvestorOmnes Capital

Round Details and Background

AlgoTherapeutix raised $21453404 on 2023-03-14 in Series B

AlgoTherapeutix is the operator of a biotechnology company designed to develop topical treatments for complex pain.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 24, 2020
Series A - AlgoTherapeutix
2-12.0M
Nov 20, 2019
Seed Round - AlgoTherapeutix
1-2.9M
Mar 14, 2023
Series B - AlgoTherapeutix
5-21.5M
Mar 14, 2023
Grant - AlgoTherapeutix
1-1.1M

Recent Activity

There is no recent news or activity for this profile.